TITLE

Patents Related to Cancer Stem Cell Research

AUTHOR(S)
Wu, Wei
PUB. DATE
January 2010
SOURCE
Recent Patents on DNA & Gene Sequences;Jan2010, Vol. 4 Issue 1, p40
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Cancer has long been viewed as a heterogeneous population of cells. Cancerous cells may often originate from the transformation of normal stem cells, similar signaling pathways may regulate self-renewal in stem cells and cancer cells. The concept that cancer might arise from a rare population of cells with stem cell properties was proposed for more than a century. Cancer stem cell hypothesis has began to be accepted recently due to the advances in stem cell biology and the development of new animal models to measure self-renewal that drive tumorigenesis. Cancer stem cells have been identified and purified in a variety of tumors (blood, breast, brain, colon, lung, pancreas) using unique stem cell markers such as CD44, CD133 and aldehyde dehydrogenases. Cancer stem cell gene signatures have been examined. This review will discuss the evolution of cancer stem cell research and summarize the recent patents related to the cancer stem cell markers, the methods to detect and modulate cancer stem cells and cancer stem cell-targeted treatment. With the advances in cancer stem cell research, the new patent applications, particularly the new drugs on cancer stem cells treatments are expected to be increasing.
ACCESSION #
53020512

Tags: STEM cells -- Research;  CANCER cells;  CARCINOGENESIS;  HYDROGENASE;  TUMORS;  PATENTS

 

Related Articles

  • Are Cancer Stem Cells Real? After Four Decades, Debate Still Simmers. Rowan, Karen // JNCI: Journal of the National Cancer Institute;4/15/2009, Vol. 101 Issue 8, p546 

    The article focuses on various cancer stem cells models. Stem cell model of carcinogenesis states that these cells are highly resistant to chemotherapy or radiation treatment, and may be the reason that cancers recur after disappearing. Accordingly, some believes that cancer is better explained...

  • Regulation of Stem Cell Plasticity: Mechanisms and Relevance to Tissue Biology and Cancer. Strauss, Robert; Hamerlik, Petra; Lieber, Andr�; Bartek, Jiri // Molecular Therapy;May2012, Vol. 20 Issue 5, p887 

    Embryonic stem cells (ESCs) are associated with a high degree of plasticity, which allows them to self-renew and differentiate into every somatic cell. During differentiation, ESCs follow a hierarchically organized pattern towards tissue specificity, which ultimately results in permanent cell...

  • Recent patents in stem cell research.  // Nature Biotechnology;Apr99, Vol. 17 Issue 4, p396 

    Presents information on patents on stem cell research. Subject of the research; Name of assignee; Status.

  • Say no to stem cell patents. Coghlan, Andy // New Scientist;5/18/2002, Vol. 174 Issue 2343, p5 

    Reports the stand of the European Group on Ethics in Science and New Technologies regarding the patenting of undifferentiated stem cells. Favor on the creation of an European-wide bank of unmodififed stem cells; Influence on the type of stem cell patent applications granted by the European...

  • Increased Lysis of Stem Cells but Not Their Differentiated Cells by Natural Killer Cells; De-Differentiation or Reprogramming Activates NK Cells. Han-Ching Tseng; Arasteh, Aida; Paranjpe, Avina; Teruel, Antonia; Wendy Yang; Armin Behel; Alva, Jackelyn A.; Walter, Gina; Head, Christian; Ishikawa, Tomo-o; Herschman, Harvey R.; Cacalano, Nicholas; Pyle, April D.; Park, No-Hee; Jewett, Anahid // PLoS ONE;2010, Vol. 5 Issue 7, p1 

    The aims of this study are to demonstrate the increased lysis of stem cells but not their differentiated counterparts by the NK cells and to determine whether disturbance in cell differentiation is a cause for increased sensitivity to NK cell mediated cytotoxicity. Increased cytotoxicity and...

  • Stem cells, potential source of cancer-fighting T cells.  // Biomedical Market Newsletter;9/30/2011, Vol. 21, p814 

    The article presents the research of Penn State College of Medicine researchers that investigates the efficacy of stem cells in fighting tumor cells in Pennsylvania.

  • Opponents of stem-cell patent win restrictions. Abbott, Alison; Schmidt, Oliver // Nature;8/1/2002, Vol. 418 Issue 6897, p470 

    Reports on the restriction in the scope of patent covering technologies for purifying human and animal embryonic stem cells by the European Patent Office in 2002. Details of the patent coverage; Groups that filed objections to the patent; Claim against the methods involved in the patent; Basis...

  • Cancer cell: using inflammation to invade the host. Arias, Jos�-Ignacio; Aller, Mar�a-Angeles; Arias, Jaime // Molecular Cancer;2007, Vol. 6, p29 

    Background: Inflammation is increasingly recognized as an important component of tumorigenesis, although the mechanisms involved are not fully characterized. The invasive capacity of cancers is reflected in the classic metastatic cascade: tumor (T), node (N) and metastasis (M). However, this...

  • From cell signaling to cancer therapy. Jin Ding; Yun Feng; Hong-yang Wang // Acta Pharmacologica Sinica;Sep2007, Vol. 28 Issue 9, p1494 

    Cancer has been seriously threatening the health and life of humans for a long period. Despite the intensive effort put into revealing the underlying mechanisms of cancer, the detailled machinery of carcinogenesis is still far from fully understood. Numerous studies have illustrated that cell...

Share

Read the Article

Courtesy of your local library

Public Libraries Near You (See All)
Looking for a Different Library?

Other Topics